Alpha-GPC: Benefits, Dosage, and What the Research Actually Shows
Alpha-GPC’s trials were mostly in people with dementia. Here is what they found, the little evidence in healthy adults, the doses used and the open question on stroke risk.

Alpha-GPC’s trials were mostly in people with dementia. Here is what they found, the little evidence in healthy adults, the doses used and the open question on stroke risk.